Jing Zhou

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 290 citations · Full text

A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

Jing Zhou, Guobing� Li, Yi Zheng et al. · Autophagy · 2015 · 249 citations · Full text

Mitophagy, Chemoprevention Strategy, Apoptosis +20

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 166 citations · Full text

Spectroscopic Studies of Substrate Interactions with Clavaminate Synthase 2, a Multifunctional α-KG-Dependent Non-Heme Iron Enzyme:  Correlation with Mechanisms and Reactivities

Jing Zhou, Wendy L. Kelly, Brian O. Bachmann et al. · Journal of the American Chemical Society · 2001 · 150 citations

Clavaminate Synthase 2, Substrate Interactions, Biosynthesis +15

Circular Dichroism and Magnetic Circular Dichroism Spectroscopic Studies of the Non-Heme Ferrous Active Site in Clavaminate Synthase and Its Interaction with α-Ketoglutarate Cosubstrate

Elizabeth G. Pavel, Jing Zhou, Robert Busby et al. · Journal of the American Chemical Society · 1998 · 148 citations

Biosynthesis, Bioorganic Chemistry, Clavaminate Synthase +12